| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-04-06 | BUY | Market Buy | 바이오노트 bionote | - | 29.6K | ₩13,320 | +1.1% | ₩395M ($274K) |
| 2026-04-02 | BUY | Market Buy | 바이오노트 bionote | - | 60.0K | ₩13,330 | +1.1% | ₩800M ($555K) |
| 2026-04-01 | BUY | 신규선임 | 김락기 | moving | 3.4K | ₩14,030 | -4.0% | ₩47M ($33K) |
| 2026-03-30 | BUY | Market Buy | 바이오노트 bionote | - | 20.0K | ₩13,750 | -2.0% | ₩275M ($191K) |
| 2026-03-25 | BUY | Market Buy | 바이오노트 bionote | - | 115.6K | ₩14,070 | -4.3% | ₩1.6B ($1.1M) |
| 2026-03-24 | BUY | Market Buy | 바이오노트 bionote | - | 25.0K | ₩13,990 | -3.7% | ₩350M ($243K) |
| 2026-03-23 | BUY | Market Buy | 바이오노트 bionote | - | 15.0K | ₩13,970 | -3.6% | ₩210M ($146K) |
| 2026-03-20 | BUY | Market Buy | 바이오노트 bionote | - | 10.5K | ₩14,120 | -4.6% | ₩148M ($103K) |
| 2026-03-18 | BUY | Market Buy | 바이오노트 bionote | - | 19.4K | - | - | - |
| 2026-03-16 | BUY | Market Buy | 바이오노트 bionote | - | 10.0K | - | - | - |
| 2026-03-13 | BUY | Market Buy | 바이오노트 bionote | - | 10.0K | - | - | - |
| 2026-03-12 | BUY | Market Buy | 바이오노트 bionote | - | 14.0K | - | - | - |
| 2026-03-11 | BUY | Market Buy | 바이오노트 bionote | - | 20.8K | - | - | - |
| 2026-01-28 | BUY | 주식매수선택권 | 장재선 Jang Jae-seon | moving | 5.0K | ₩11,870 | +19.3% | ₩59M ($41K) |
| 2026-01-28 | BUY | 주식매수선택권 | 신정섭 Shin Jeong-seop | Managing Director | 10.0K | ₩11,870 | +19.3% | ₩119M ($82K) |
| 2026-01-28 | BUY | 주식매수선택권 | 전동운 Jeon Dong-woon | Managing Director | 10.0K | ₩11,870 | +19.3% | ₩119M ($82K) |
| 2026-01-02 | BUY | Market Buy | 백영옥 Baek Young-ok | CEO | 10.0K | ₩11,410 | +24.1% | ₩114M ($79K) |
| 2025-11-27 | BUY | 주식매수선택권 | 태영진 Taeyoungjin | moving | 25.0K | ₩12,470 | +13.6% | ₩312M ($216K) |
| 2025-10-15 | BUY | 주식매수선택권 | 신정섭 Shin Jeong-seop | Managing Director | 2.0K | ₩12,850 | +10.2% | ₩26M ($18K) |
| 2025-10-15 | BUY | 주식매수선택권 | 전동운 Jeon Dong-woon | Managing Director | 10.0K | ₩12,850 | +10.2% | ₩129M ($89K) |
| 2025-04-03 | BUY | 주식매수선택권 | 장재선 Jang Jae-seon | moving | 15.0K | ₩10,830 | +30.8% | ₩162M ($113K) |
| 2025-04-03 | BUY | 주식매수선택권 | 신정섭 Shin Jeong-seop | Managing Director | 10.0K | ₩10,830 | +30.8% | ₩108M ($75K) |
| 2025-04-03 | BUY | 주식매수선택권 | 최영진 Youngjin Choi | Managing Director | 5.0K | ₩10,830 | +30.8% | ₩54M ($38K) |
| 2024-08-20 | BUY | 주식매수선택권 | 전동운 Jeon Dong-woon | moving | 5.0K | ₩11,930 | +18.7% | ₩60M ($41K) |
| 2024-08-20 | BUY | 주식매수선택권 | 채수민 Chae Su-min | moving | 19.0K | ₩11,930 | +18.7% | ₩227M ($157K) |
| 2024-08-20 | SELL | Market Sell | 채수민 Chae Su-min | moving | -10.0K | ₩11,930 | -18.7% | ₩119M ($83K) |
| 2024-05-29 | BUY | Market Buy | 바이오노트 bionote | - | 2.2K | ₩12,700 | +11.5% | ₩28M ($19K) |
| 2024-05-28 | BUY | Market Buy | 바이오노트 bionote | - | 14.8K | ₩12,360 | +14.6% | ₩183M ($127K) |
| 2024-05-24 | BUY | Market Buy | 바이오노트 bionote | - | 19.0K | ₩12,180 | +16.3% | ₩231M ($161K) |
| 2024-04-15 | BUY | Market Buy | 바이오노트 bionote | - | 53.4K | ₩13,900 | +1.9% | ₩742M ($515K) |
| 2024-04-12 | BUY | Market Buy | 바이오노트 bionote | - | 15.5K | ₩12,070 | +17.3% | ₩187M ($130K) |
| 2024-04-12 | BUY | Market Buy | 바이오노트 bionote | - | 51.7K | ₩12,070 | +17.3% | ₩624M ($433K) |
| 2024-04-11 | BUY | Market Buy | 바이오노트 bionote | - | 86.8K | ₩12,000 | +18.0% | ₩1.0B ($723K) |
| 2024-04-11 | BUY | Market Buy | 바이오노트 bionote | - | 8.5K | ₩12,000 | +18.0% | ₩102M ($71K) |
| 2024-04-09 | BUY | Market Buy | 바이오노트 bionote | - | 33.8K | ₩12,400 | +14.2% | ₩419M ($291K) |
| 2024-04-08 | BUY | Market Buy | 바이오노트 bionote | - | 55.8K | ₩11,980 | +18.2% | ₩669M ($465K) |
| 2024-04-05 | BUY | Market Buy | 바이오노트 bionote | - | 1.4K | ₩12,120 | +16.8% | ₩16M ($11K) |
| 2024-04-05 | SELL | 증여 | 박영신 Youngshin Park | Managing Director | -39.0K | ₩12,120 | -16.8% | ₩473M ($328K) |
| 2024-04-04 | BUY | 주식매수청구권 행사 | 신정섭 Shin Jeong-seop | Managing Director | 6.0K | ₩12,030 | +17.7% | ₩72M ($50K) |
| 2024-04-04 | BUY | Market Buy | 바이오노트 bionote | - | 77.8K | ₩12,030 | +17.7% | ₩936M ($650K) |
| 2024-03-26 | BUY | 신규선임 | 허태영 Taeyoung Heo | CEO | 2.0K | ₩12,500 | +13.3% | ₩25M ($17K) |
| 2024-03-22 | BUY | Market Buy | 바이오노트 bionote | - | 5.5K | ₩12,770 | +10.9% | ₩71M ($49K) |
| 2024-03-07 | BUY | Market Buy | 바이오노트 bionote | - | 46.0K | ₩12,590 | +12.5% | ₩580M ($403K) |
| 2024-03-06 | BUY | Market Buy | 바이오노트 bionote | - | 13.7K | ₩12,700 | +11.5% | ₩174M ($121K) |
| 2023-09-20 | BUY | Market Buy | 최영진 Youngjin Choi | Managing Director | 100 | ₩12,300 | +15.1% | ₩1M ($854) |